Atlas Trials

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Clinical trial NCT01503437 · COMPLETED

Trial details

NCT number
NCT01503437
Sponsor
Dr. Reddy's Laboratories Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fasting
Start date
2006-11-01
Primary completion
2006-11-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.